iGan Partners
Venture Capital
Active
Toronto, Canada
42
4M
28
3.23
9
0.33
8
- Stages of investment
- Areas of investment
Summary
In 2011 was created iGan Partners, which is appeared as VC. The venture was found in North America in Canada. The leading representative office of defined VC is situated in the Toronto.
This organization was formed by Sam Ifergan. We also calculated 4 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the iGan Partners, startups are often financed by MaRS Investment Accelerator Fund, Right Side Capital Management, LVL1 Group. The meaningful sponsors for the fund in investment in the same round are Rho Canada Ventures, Motorola Solutions Venture Capital, MaRS Investment Accelerator Fund. In the next rounds fund is usually obtained by LVL1 Group, Lumira Ventures, Upfront Ventures.
The average startup value when the investment from iGan Partners is 1-5 millions dollars. Deals in the range of 1 - 5 millions dollars are the general things for fund. The real fund results show that this VC is 22 percentage points more often commits exit comparing to other companies. This iGan Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2018. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.
The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are FinTech, Health Care. Among the most popular portfolio startups of the fund, we may highlight Think Research, Flosonics, Rna Diagnostics.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 42
- Lead investments
- 9
- Exits
- 8
- Rounds per year
- 3.23
- Follow on index
- 0.33
- Investments by industry
- Health Care (22)
- Software (13)
- Medical (13)
- Medical Device (10)
- Artificial Intelligence (8) Show 57 more
- Investments by region
-
- Canada (38)
- United Kingdom (1)
- United Arab Emirates (1)
- United States (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 222K
- Group Appearance index
- 0.69
- Avg. company exit year
- 5
- Avg. multiplicator
- 0.06
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Hyivy Health Inc. | 18 Jan 2022 | Medical Device, Medical, Personal Health, Home Health Care, mHealth, Rehabilitation | Seed | 1M | Ontario, Hamilton, Canada |
Flosonics | 19 Mar 2024 | Health Care, Medical Device, Medical | Late Stage Venture | 20M | Ontario, Greater Sudbury, Canada |
Ronawk | 07 Jul 2022 | Biotechnology, Health Care, Biopharma | Seed | 1M | United States, Kansas, Olathe |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.